AVXL logoAVXL
Anavex Life Sciences Corp

23,387
Loading...
Loading...
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
42

Frequently Asked Questions

What is Market Cap of Anavex Life Sciences Corporation?
What is the 52-week high for Anavex Life Sciences Corporation?
What is the 52-week low for Anavex Life Sciences Corporation?
What is Anavex Life Sciences Corporation stock price today?
What was Anavex Life Sciences Corporation stock price yesterday?
What is the PE ratio of Anavex Life Sciences Corporation?
What is the Price-to-Book ratio of Anavex Life Sciences Corporation?
What is the 50-day moving average of Anavex Life Sciences Corporation?
How many employess does Anavex Life Sciences Corporation has?

Latest AVXL News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.